Japan Lifeline Co (TSE:7575) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:7575 Japan Lifeline Co Ltd TSE:7575
84 GF Score
Price 円1,371.00
GF Value 円1,535.81
Valuation Modestly Undervalued
View Full Analysis

What is Japan Lifeline Co FFO?

FFO (Funds from operations) only applies to REITs.

TSE:7575
84GF Score
Japan Lifeline Co Ltd TSE:7575
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Japan Lifeline Co (TSE:7575) Overvalued in 2026?

Based on GuruFocus' analysis, Japan Lifeline Co stock appears to be undervalued. The current stock price of 円1,371.00 is trading 10.7% below its estimated GF Value™ of 円1,535.81. GuruFocus considers Japan Lifeline Co to be Modestly Undervalued.

Key valuation signals for TSE:7575:

  • FFO:
  • GF Value™: 円1,535.81 vs. price of 円1,371.00 (10.7% below fair value)
  • GF Score™: 84/100

No single metric tells the full story. See the TSE:7575 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Japan Lifeline Co Business Description

Other Exchanges L8B:Germany
Address 2-2-20, Higashishinagawa, Tennoz Ocean Square, 25th Floor, Shinagawa-ku, Tokyo, JPN, 140-0002
Japan Lifeline Co Ltd is a medical device company operating in Japan. It is engaged in the trading and manufacturing of medical devices specialized in the cardiovascular field. The company offers medical devices mainly for the treatment of cardiac and vascular diseases. It focuses on providing implantable devices to treat arrhythmias; disposable catheter devices with electrodes for diagnosis and treatment of arrhythmias; prosthetic devices to replace blood vessels and heart valves that lost their functions; and devices for intravascular treatment of cardiac infarction, arterial occlusions of the lower extremities and congenital cardiac diseases.
84GF Score

Get the complete analysis for TSE:7575

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,371.00
Price
円1,535.81
GF Value